COLUMBIA, Md.--(BUSINESS WIRE)--Osiris Therapeutics, Inc. (NASDAQ: OSIR), the leading cellular regenerative medicine company focused on developing and marketing products to treat conditions in wound care, orthopaedics and sports medicine, will present findings of three wound care related studies this Friday, October 17, at the Symposium on Advanced Wound Care in Las Vegas, Nevada.
“As a pioneer in cellular regenerative medicine dedicated to advancing the field of wound care, Osiris has developed a proprietary system for tissue processing and cryopreservation with the goal of closing chronic wounds better and faster, while also reducing overall healthcare costs,” said Lode Debrabandere, President and CEO at Osiris. “These studies demonstrate the optimal benefits of cryopreserved placental membranes, which maintain the structural and cellular integrity of the native tissue, on hard-to-close chronic wounds.”
Help employers find you! Check out all the jobs and post your resume.
“As a pioneer in cellular regenerative medicine dedicated to advancing the field of wound care, Osiris has developed a proprietary system for tissue processing and cryopreservation with the goal of closing chronic wounds better and faster, while also reducing overall healthcare costs,” said Lode Debrabandere, President and CEO at Osiris. “These studies demonstrate the optimal benefits of cryopreserved placental membranes, which maintain the structural and cellular integrity of the native tissue, on hard-to-close chronic wounds.”
Help employers find you! Check out all the jobs and post your resume.
